|
Viral transfer technology
|
|
Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells
|
1613
|
|
D Nègre, P-E Mangeot, G Duisit, S Blanchard, P-O Vidalain, P Leissner, A-J Winter, C Rabourdin-Combe, M Mehtali, P Moullier, J-L Darlix & F-L Cosset
|
| Abstract Full Article PDF
|
 |
|
Transcriptionally active drugs improve adenovirus vector performance in vitro and in vivo
|
1624
|
|
C Gaetano, A Catalano, R Palumbo, B Illi, G Orlando, G Ventoruzzo, F Serino & MC Capogrossi
|
| Abstract Full Article PDF
|
| |
|
|
Inherited disease
|
|
Tissue-specific expression and long-term deposition of human collagen VII in the skin of transgenic mice: implications for gene therapy
|
1631
|
|
E Sat, KH Leung, L Bruckner-Tuderman & KSE Cheah
|
| Abstract Full Article PDF
|
| |
|
|
Acquired diseases
|
|
Transcriptional targeting of adenoviral gene delivery into migrating wound keratinocytes using FiRE, a growth factor-inducible regulatory element
|
1640
|
|
P Jaakkola, M Ahonen, V-M Kähäri & M Jalkanen
|
| Abstract Full Article PDF
|
| |
|
Quantitation of HSV mass distribution in a rodent brain tumor model
|
1648
|
|
D Schellingerhout, NG Rainov, XO Breakefield & R Weissleder
|
| Abstract Full Article PDF
|
| |
|
A lentiviral vector expressing a fusogenic glycoprotein for cancer gene therapy
|
1656
|
|
RM Diaz, A Bateman, L Emiliusen, A Fielding, D Trono, SJ Russell & RG Vile
|
| Abstract Full Article PDF
|
| |
|
In vivo transfer of human hepatocyte growth factor gene accelerates re-endothelialization and inhibits neointimal formation after balloon injury in rat model
|
1664
|
|
K Hayashi, S Nakamura, R Morishita, A Moriguchi, M Aoki, K Matsumoto, T Nakamura, Y Kaneda, N Sakai & T Ogihara
|
| Abstract Full Article PDF
|
| |
|
Interleukin-18 gene transfer increases antitumor effects of suicide gene therapy through efficient induction of antitumor immunity
|
1672
|
|
DW Ju, Y Yang, Q Tao, WG Song, L He, G Chen, S Gu, CC Ting & X Cao
|
| Abstract Full Article PDF
|
| |
|
|
Cell-based therapy
|
|
Dendritic cells infected with recombinant fowlpox virus vectors are potent and long-acting stimulators of transgene-specific class I restricted T lymphocyte activity
|
1680
|
|
M Brown, Y Zhang, S Dermine, EA de Wynter, C Hart, H Kitchener, PL Stern, MA Skinner & SN Stacey
|
| Abstract Full Article PDF
|
| |
|
|
Nonviral transfer technology
|
|
Supramolecular structure and nuclear targeting efficiency determine the enhancement of transfection by modified polylysines
|
1690
|
|
C-K Chan, T Senden & DA Jans
|
| Abstract Full Article PDF
|
| |
|
Co-polymer of histidine and lysine markedly enhances transfection efficiency of liposomes
|
1698
|
|
Q-R Chen, L Zhang, SA Stass & AJ Mixson
|
| Abstract Full Article PDF
|
| |
|
|
Correspondence
|
|
Comment on the use of the cre/loxP recombinase system for gene therapy vectors
|
1706
|
|
SD Scott & B Marples
|
| Full Article PDF
|
| |
| |
| |
